phenotypeId,phenotypeName,clinicalDescription
192675000,Biliary cirrhosis,Overview: a disease of immune system with T-cell mediated attack on intralobular hepatic bile ducts. Presentation: Patients may be asymptomatic or may have signs and symptoms of cholestasis like fatigue to pruritus. Assessment: liver enzyme with alkaline phosphatase elevation. antimitochondrial antibodies (AMA) is considered serologic hallmark. Plan: symptom management. Disease progression may be slowed with ursodeoxycholic acid. Prognosis: long term disease that may progress with portal hypertension and/or hepatocellular carcinoma.
